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The experimental method comparative genomic hybridization (CGH) array provides a full
picture of chromosome ampliﬁcations and deletions of an individual’s genome. The multi-
dimensional nature of these data, however, has not been fully explored. Current methods
for CGH analysis focus on speciﬁc markers, but deeper understanding can be gained by
examining the properties of the overall genomic proﬁle. In this paper we propose a novel
method for characterizing CGH proﬁles mathematically using algebraic homology. We apply
our method to breast cancer CGH proﬁles from patients that have been subjected to
different treatments. We show that our results obtained using homology are in agreement
with previous studies and are able to distinguish between frequency of cancer recurrence
in chemotherapy and non-treated patient populations.
© 2009 Elsevier B.V. All rights reserved.
1. Introduction
The use of topology in technology and the natural sciences has greatly increased during the past two decades. In par-
ticular, algebraic topology has been used to address a wide variety of problems. For instance, Krishan et al. used algebraic
topology to extract consistent and robust geometric properties from the weakly turbulent state of Rayleigh Benard con-
vection, known as spiral defect chaos [9]. Cruz-White proposed to use homology and cohomology to prove necessary and
suﬃcient conditions for the formation of spiral waves in excitable media [4] and Nakanishi developed a new method that
uses homology groups to study genetic algorithms [8].
One of the most promising applications of homology to the understanding of biological systems is that of persistent
homology. This method was developed by H. Edelsbrunner and colleagues as an algebraic tool for measuring topological
features of clouds of points encountered in the representation of high-dimensional data [5]. For example, persistent homol-
ogy has been applied to the study of protein structure [15], sensor networks [12], and neural activity in cells exposed to
different stimuli [13].
Here, we extend applications of computational homology to the analysis of genomic data from cancer patients. We center
our study on breast cancer, the most frequent tumor in women worldwide [2]. Because of the lack of reliable predictors
of outcome, many women who are at low risk of disease recurrence are unnecessarily subjected to aggressive treatment,
while others with high risk of recurrence often develop resistance to treatment in a rather short period of time. Therefore,
in order to improve clinical outcomes, it is necessary to understand how to select individual patients who may most beneﬁt
from treatment. This problem motivates our study.
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Number of patients in treatment groups with respective cancer recurrence information. “No recurrence”
is deﬁned as over 60 months of disease free survival without recurrence. A total number of 154 patients
were analyzed. The remaining 27 were excluded from the study due to the lack of follow-up.
Anthracycline-based chemotherapy No chemotherapy
Cancer recurrence 25 22
No cancer recurrence 58 49
Total 83 71
Percent recurrence 30.12% 30.99%
A number of molecular markers have been proposed for the prediction of breast cancer prognosis (i.e. prediction of
disease progression) or treatment. One such example is the proﬁle of genomic alterations of the tumor [6]. Genomic in-
stability, one of the main characteristics of cancer, leads to DNA copy number changes. Copy number changes consist of
ampliﬁcations and deletions where different chromosome regions appear multiple times or are deleted when compared to
the genome of a healthy cell, respectively. These genomic alterations are associated with cancer progression and prognosis
[7] and can be detected using a high throughput experimental technique called comparative genomic hybridization (CGH)
arrays [10]. A wide variety of purely statistical methods have been proposed to analyze and identify signiﬁcant patterns of
DNA copy number methods (reviewed in [2,14]). However, proper analysis of CGH proﬁles is subject to diﬃculties due to
the complex patterns of ampliﬁcations and deletions commonly observed. Towards this end, new mathematical tools must
be developed.
Here we propose to use homological methods to address this problem. For consistency we not only include the mathe-
matical methods but also provide a short description of the experimental methods and results. Next, we analyze the data
using the 0-Betti numbers (β0) and ﬁnd, in agreement with previous studies [1], that (β0) can distinguish between re-
current and non-recurrent groups in a set of patients not treated with chemotherapy. In the last section, we discuss the
implications of our results as well as future lines of research.
2. Methods: experimental and mathematical
2.1. Comparative genomic hybridization
In array CGH, equal amounts of patient tumor DNA and reference DNA from healthy individuals are ﬂuorescently labeled
with different ﬂours: green label for tumor and red for reference DNA. These samples are co-hybridized to a microscope
slide, called microarray. Each microarray contains 2,460 spots, see Fig. 1. Each spot contains many copies of the same short
DNA sequence, called clones. In the experiments analyzed here clones are spread throughout the entire genome at an average
distance of 1.4 Mb. Variation in copy number is measured by ﬁnding the relative binding of tumor and reference DNA to
each clone, and is reported as the log2 ratio of tumor DNA ﬂuorescence to reference DNA ﬂuorescence. A small sample of
CGH data can be seen in Fig. 2(A).
2.2. Clinical and genomic proﬁles of breast cancer patients
The data set and CGH methods used in this study have been previously described in Climent et al. [1] Brieﬂy, genome-
wide analysis of gene copy number variation was performed by CGH array on tumors taken from 181 female patients with
stages I and II lymph node-negative breast cancer (NNBC), that is patients in which the tumor had not spread to the lymph
nodes. For our analysis, CGH data was ordered by the position of the clones in the genome. Position for each clone was
determined by the March 2006 assembly of the human genome in the UCSC Genome Browser. Clinically relevant information
such as treatment, months of disease free survival, and whether or not the cancer recurred is included for all patients in
the published study [1]. This information is relevant to our study.
Of the 181 patients in our data set, 90 received anthracycline-based chemotherapy following surgery, and 91 did not. We
subdivided each of these groups based on clinical deﬁnitions of cancer recurrence. No recurrence was deﬁned as no cancer
reappearance for over ﬁve years. Recurrence was taken to be cancer relapse after any length of time. By these guidelines,
27 patients were excluded from our study because although they had not recurred, they had not been followed for 60
months. The ﬁnal breakdown of patients is shown in Table 1.
2.3. Computational homology
We aim to analyze the underlying trends in the CGH proﬁles for each patient using homology. To this end we deﬁne a
surface using the data. First, the CGH data is mapped to a cloud of points in space. This is performed by sliding a window
of length n across the data, and mapping each consecutive set of n points to a single point in Rn . This method is illustrated
in Fig. 2 for n = 2. Fig. 2(A) shows an idealized CGH proﬁle. The x-axis represents the genomic position of the CGH data in
the chromosome and the y-axis shows the log2 ratio between ﬂuorescent labels (green vs. red). Points above the y = 0 line
represent ampliﬁcations, those below represent deletions. Due to experimental noise one expects to see variations above
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number shown in green, and deletions in red. Windows to the right show a magniﬁed view of log2 ratios of tumor DNA to reference DNA for chromosomes
8 (above) and 16 (below). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
and below the x-axis that even when the ratio of the two signals are equal. Fig. 2(A) takes this into consideration. A window
expanding along the ﬁrst two CGH data points is shown in purple. These two points deﬁne a point in the plane (shown in
purple in Fig. 2(B)) whose x-coordinate is the log2 ratio of the ﬁrst CGH data point and the y-coordinate is given by the log2
ratio of the second CGH data point. Notice that by this method the relative value between consecutive clones is preserved,
however the actual positions of the clones along the chromosome are lost. Next the window is slided one position towards
the right (Fig. 2(A)). This makes the second CGH value the x-coordinate and the third CGH value the y-coordinate of the
second point in the cloud of points (Fig. 2(B)). Although the following observation is not critical for the results of this paper
it is important to mention that by this method most of the CGH data values near the x-axis are mapped to points near the
origin and all the noise of the data will be mapped to that region. On the other hand, a true deletion or ampliﬁcation (e.g.
fourth data point of the CGH proﬁle in Fig. 2(A)) deﬁnes two points far from the main cloud of points as shown in red in
Fig. 2(B). The net effect of this approach is that the CGH proﬁle gives rise to a cloud of points spread over the plane mapping
the noise near the origin and copy number changes away from the origin. Taking wider windows, extending over three or
more points in the CGH proﬁle, will deﬁne points in three or higher dimensions. Importantly we expect that single point
ampliﬁcations and deletions are better detected for n = 2 while longer ones (that is those that involve multiple consecutive
clones) will be detected in higher dimensions.
In more precise terms, suppose there are m clones on one chromosome with corresponding log2 ratio values {xi}mi=1 on
the CGH proﬁle. Then the cloud of points in Rn is deﬁned by m points, {vi}mi=1, where
vi = (xi, xi+1, . . . , xi+(n−1)).
To ensure that each clone is represented an equal number of times, we use xi = xi mod m for all i >m.
Since working with the entire genome is very computationally expensive, we show here as a proof of principle our
results for individual chromosomes. Whole genome studies will be adressed in a future publication.
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represents the log2 ratio of tumor DNA to reference DNA clone copy number. (B) The window maps each consecutive set of n points to one point in R
n .
To analyze these cloud of points arising from CGH data, we use the software PLEX [11], initially developed by Vin de Silva.
The program takes as an input an n ×m matrix of m points in n dimensions. It takes the ith column to the n-dimensional
vector
vi = (xi, xi+1, . . . , xi+(n−1)).
Using these vectors {vi}mi=1 as vertices, and given a speciﬁed radius  , PLEX calculates a boolean pairwise distance matrix G ,
where for each pair of vertices vi and v j ,
Gi, j =
{
1 if |vi − v j| < ,
0 otherwise.
G is a connectivity matrix used to construct the Rips simplicial complex. In particular, two vertices vi and v j are
connected to form a 1-simplex if |vi − v j | <  .
If for three vertices vi , v j , and vk , all three pairwise distances are less than  , then each of the three 1-simplices
connecting the pairs of points will be in the complex. In this case, the 2-simplex deﬁned by the three 1 simplices is added
to the complex as well. This process is continued inductively, building the simplicial complex by adding higher simplices
whenever all of their lower sub-simplices are present in the complex [3]. Once the simplicial complex has been constructed,
PLEX can calculate its Betti numbers.
The Betti numbers of a simplicial complex representing a discrete data set will be heavily dependent on the radius 
chosen. Fig. 3 illustrates this idea. It shows three surfaces created from the idealized CGH data shown in Fig. 2. These
surfaces are built by connecting points within a ﬁxed radius  (as explained above). For suﬃciently small  , each point is
its own connected component. As  increases, points connect to form larger simplices with interspersed holes. Eventually,
for suﬃciently large  all points will join to form one single, simply connected component. Information about a data set
can be gained by constructing simplicial complexes for several radii, and calculating the Betti numbers of each of these
complexes. To quantify differences between the populations with recurrent and non-recurrent cancer, we ﬁnd the average
Betti number β0 of the complexes generated over a range of radii for each group. We then look at the radii at which the
average β0 values of the two populations differ the most. Finally we determine if this difference is statistically signiﬁcant,
as detailed in the next section.
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2.4. Statistical analysis
To test statistical signiﬁcance, we assume the null hypothesis that at a given radius, the average Betti number β0 of a
sample of patients is independent of their cancer recurrence and treatment. The following was performed twice, once to
compare with anthracycline-treated patients, and once for the non-chemotherapy treated patients. Using a range of radii,
we ﬁrst construct simplicial complexes for all patients, regardless of treatment or outcome, and calculate β0 for each. We
then randomly assign each patient to a particular outcome so as to have the same number of recurrent and non-recurrent
patients as in our experimental data. Within each group, we compute the average β0 value, and ﬁnd the absolute value of
the difference of the two. The p-values are calculated as the number of times the β0 value of the randomized data sets
differs by more than that of the actual data, divided by the number of times the simulation is performed. For p-values
of 0.05 and below, the null hypothesis is rejected and we conclude that the average β0 value is associated with cancer
recurrence.
3. Results
3.1. CGH proﬁles
Climent et al. showed that the deletion of the q-arm of chromosome (denoted by 11q) predicts response to anthracycline-
based chemotherapy (AC) [1]. To deﬁne the common genomic signature of NNBC (Node Negative Breast Cancer), the authors
searched for clones that showed abnormal log2 values in more than 15% of the samples. A total of 112 clones that were
mapped to 40 different chromosome loci in 9 different chromosome arms were found (or described as copy number
changes). These corresponded to 23 genomic ampliﬁcations and 17 genomic deletions involving regions known to be com-
monly involved in breast cancer as well as uncharacterized genomic aberrations (Fig. 4). They next compared the genomic
proﬁles of tumors in the AC and non-AC groups of treatment. None of the abnormal clones showed a signiﬁcantly different
distribution between the two cohorts, indicating that both groups were comparable at the genomic level. However, when the
genomic proﬁles were compared to ﬁnd differences with the recurrence status of the patients, they found that patients in
the non-AC group whose tumor genome presented deletion of the 11q chromosomal region showed an elevated frequency
of recurrence compared with those without the 11q deletion.
162 D. DeWoskin et al. / Topology and its Applications 157 (2010) 157–164Fig. 4. Frequency of genomic ampliﬁcations and deletions for all patients from [1] as detected by CGH. Chromosomes are separated by solid lines and
labeled above and below. Ampliﬁcations (top) are shown in green, and deletions (bottom) in red. (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 5. Chromosome 11 plots of average Betti numbers β0 in dimension 2 calculated for recurrent and non-recurrent data, over a range of radii  between
0.01 and 0.16 in the following patient groups: A. Patients treated with chemotherapy (AC group); B. Patients non-treated with chemotherapy (non-AC
group). Both plots show the curves converging at relatively small  making it hard to distinguish signiﬁcant differences in the populations.
3.2. Chromosomes with high levels of genomic instability
By visual inspection of the CGH proﬁle one can see that a number of chromosomes have high genomic instability (Fig. 4).
In this work we show results for chromosomes 8 and 11. We ﬁrst analyzed chromosome 11 to see if our analysis would
reproduce the ﬁndings from [1]. We found that the rank of H0 for the surfaces generated from chromosome 11 CGH data
gave results consistent with the previously published statistical analyses [1]. We ﬁrst analyzed the data in dimension two.
As mentioned earlier we expected that single clone ampliﬁcations or deletions would have a larger effect on the topology
of the deﬁned surface. However we also expected that mapping CGH data to a cloud of points in two dimensions would not
create suﬃcient distance between points to allow us to see clear differences between the treatment groups over a range
of radii. Fig. 5 shows the results for each of the AC and non-AC groups. We plotted and compared the average β0 values
for recurrent and non-recurrent patient groups over radii ranging from 0.01 to 0.16. The fast growth of the simplices with
small increases in radius make the β0 values quickly converge to a steady value. It is interesting to note that despite the
simplicity of mapping points to the plane, differences between the two groups are observed for small radii. At a radius
of 0.03, we calculated a p-value of 0.07 for the non-AC group, nearing statistical signiﬁcance. Such statistical signiﬁcance
was not observed for the AC group.
At higher dimensions, d  3, we began to see a difference in the average Betti number β0 between the recurrent and
non-recurrent populations in the non-AC group that extended over larger ranges of radii. Importantly, and consistent with
the published data and with our results in dimension n = 2, no such distinction ever appeared in the chemo group. Fig. 6
below shows that over an intermediate range of radii, β0 is signiﬁcantly higher in the recurrent group of non-AC patients
as compared to the non-recurrent group (p ≈ 0.05 at  = 0.1). This ﬁnding suggests that increased genetic instability, as
measured by β0, is correlated with worse prognosis.
Chromosome 8 also showed large regions of ampliﬁcations and deletions (Fig. 4), and was also reported to have p-values
that were very close to statistical signiﬁcance. Therefore, we anticipated that under our analysis, it should show a similar
pattern to that found in chromosome 11. Fig. 7 shows the same comparison of average Betti number β0 for chromosome 8
as we performed for chromosome 11. Results were consistent, and a signiﬁcant difference was found between the average
β0 values of recurrent and non-recurrent patients in the non-chemotherapy group only (p ≈ 0.025 at  = 0.1).
D. DeWoskin et al. / Topology and its Applications 157 (2010) 157–164 163Fig. 6. Chromosome 11 plots of average Betti numbers β0 in dimension 4 calculated for recurrent and non-recurrent data, over a range of radii  between
0.01 and 0.22 in the following patient groups: A. Patients treated with chemotherapy (AC group); B. Patients non-treated with chemotherapy (non-AC
group). The curves show a signiﬁcant difference in average Betti number in the non-AC group (p ≈ 0.05 at  = 0.1) but not for the patients in the AC group
(p ≈ 0.65 at  = 0.1).
Fig. 7. Chromosome 8 plots of average Betti numbers β0 in dimension 4 calculated for recurrent and non-recurrent data, over a range of radii  between 0.01
and 0.25 in the following patient groups: A. Patients treated with chemotherapy (AC group); B. Patients non-treated with chemotherapy (non-AC group).
Non-AC patients have signiﬁcantly higher β0 (p ≈ 0.025 at  = 0.1) values in the recurrent population. This is not the case for AC patients (p ≈ 0.83 at
 = 0.1).
3.3. Chromosomes with low instability
In order to verify that our method did not have any built in bias towards the results shown, we tested chromosome 19
since the CGH data for this chromosome showed little variation in gene copy number for both the AC and non-AC groups.
As can be seen in Fig. 8, the homology of the cloud of points constructed from chromosome 19 CGH values shows no
signiﬁcant difference between any of the test groups (p  0.19 at all radii).
4. Discussion and conclusions
CGH arrays are commonly used for the detection of chromosome ampliﬁcations and deletions in cancer and in genetic
diseases. However CGH proﬁles are very complex in nature and diﬃcult to analyze. Current statistical methods have been
very successful at segmenting the data and ﬁnding speciﬁc clones associated with the progression of the disease. However
more mathematical methods are needed to fully exploit the information they carry.
In this study, we used homology to study the CGH proﬁles of 154 breast cancer patients in the early stages of cancer
development (stages I and II), and in which the tumor had not spread to the lymph-nodes. The most important feature of
this approach is that no segmentation of the data is needed. Also in our method, one can simultaneously study the data at
various scales by looking at windows of different sizes, and consequently different dimensional point clouds. Our current
method, as presented here, has the disadvantage that it does not locate speciﬁc clones but rather gives an overall view of
the behavior of the data.
In our study we were able to detect signiﬁcant differences in the underlying nature of gene copy number data of recur-
rent and non-recurrent patients who did not receive anthracycline-based chemotherapy after surgery (the non-AC group).
For the patients treated with anthracycline (the AC group), no signiﬁcant difference was found between the average β0
values for recurrent and non-recurrent patients.
164 D. DeWoskin et al. / Topology and its Applications 157 (2010) 157–164Fig. 8. Chromosome 19 plots of average Betti numbers β0 in dimension 4 calculated for recurrent and non-recurrent data, over a range of radii  between
0.01 and 0.3 in the following patient groups: A. Patients treated with chemotherapy (AC group); B. Patients non-treated with chemotherapy (non-AC group).
Neither curve shows a signiﬁcant difference in average Betti number between the recurrent and non-recurrent sets of patients (p 0.19 at all radii).
It is interesting to observe that the difference between average β0 for the recurrent and non-recurrent patients in the
non-AC group became signiﬁcant only after looking at clouds of points in Rn with n 3. Furthermore, at higher dimensions,
we consistently obtained smaller p-values. Since the contribution of single clone copy number changes are less signiﬁcant
in higher dimensions, this ﬁnding suggests that large copy number changes are more closely related with prognosis than
smaller ones.
In the future we plan to extend these studies to whole genome investigations, we also will investigate the homology
groups Hk with k  1 to gain a deeper understanding of patterns within the data. Preliminary analysis of H1 is consistent
with the model proposed above.
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